aUCBT is a valuable curative option in pediatric patients with refractory idiopathic SAA and no available matched sibling or unrelated donors. Experience in the use of autologous cord blood units in patients with SAA is limited and private for-profit cord blood-banking programs are controversial. We report the successful treatment of two patients with SAA, aged 15 and 24 months, with autologous cord blood combined with immunosuppression. After conditioning with 200 mg/kg cyclophosphamide and ATG, 7.5 mg/kg, 32.2 × 10⁷/kg, and 3.8 × 10⁷/kg autologous cord blood nucleated cells were infused, respectively. One of our patients underwent transplantation after failure of IST. Both patients received post-transplant immunosuppression with cyclosporine for 12 months. They remain disease-free 6 years post-transplantation.

REFERENCES

1Peslak SA, Olson T, Babushok DV. Diagnosis and treatment of aplastic anemia. Curr Treat Options Oncol. 2017; 18(12): 70.
10.1007/s11864-017-0511-z
PubMed Web of Science® Google Scholar
2Peffault de Latour R, Chevret S, Jubert C, et al. Unrelated cord blood transplantation in patients with acquired refractory aplastic anemia: a nationwide phase II study. Blood. 2018; 132(7): 750-754.
10.1182/blood-2018-01-829630
CAS PubMed Web of Science® Google Scholar
3Bacigalupo A, Sica S. Alternative donor transplants for severe aplastic anemia: current experience. Semin Hematol. 2016; 53(2): 115-119.
10.1053/j.seminhematol.2016.01.002
PubMed Web of Science® Google Scholar
4Koza V, Jindra P, Svojgrova M, Cetkovsky P. Successful autologous transplantation in a patient with severe aplastic anemia (SAA). Bone Marrow Transplant. 1998; 21(9): 957-959.
10.1038/sj.bmt.1701216
CAS PubMed Web of Science® Google Scholar
5Balint B, Stamatovic D, Todorovic M, et al. Autologous transplant in the treatment of severe aplastic anemia—a case report. Transfus Apher Sci. 2011; 45(2): 137-141.
10.1016/j.transci.2011.07.008
PubMed Web of Science® Google Scholar
6Frangoul H, Navarro WH, Confer DL, Jagasia M. Infusion of autologous peripheral blood stem cells in an unrelated donor who developed severe aplastic anemia following stem cell donation. Bone Marrow Transplant. 2012; 47(6): 869.
10.1038/bmt.2011.174
CAS PubMed Web of Science® Google Scholar
7Fruchtman SM, Hurlet A, Dracker R, et al. The successful treatment of severe aplastic anemia with autologous cord blood transplantation. Biol Blood Marrow Transplant. 2004; 10(11): 741-742.
10.1016/j.bbmt.2004.07.003
PubMed Web of Science® Google Scholar
8Buchbinder D, Hsieh L, Puthenveetil G, et al. Successful autologous cord blood transplantation in a child with acquired severe aplastic anemia. Pediatr Transplant. 2013; 17(3): E104–E107.
10.1111/petr.12068
CAS PubMed Web of Science® Google Scholar
9Liang C, Wei J, Jiang E, et al. Successful treatment of a 3-year-old boy with hepatitis-associated aplastic anemia with combination of auto-umbilical cord blood transplantation and immunosuppressive therapy. Transfus Apher Sci. 2015; 52(2): 211-213.
10.1016/j.transci.2014.12.021
PubMed Web of Science® Google Scholar
10Rosenthal J, Woolfrey AE, Pawlowska A, Thomas SH, Appelbaum F, Forman S. Hematopoietic cell transplantation with autologous cord blood in patients with severe aplastic anemia: an opportunity to revisit the controversy regarding cord blood banking for private use. Pediatr Blood Cancer. 2011; 56(7): 1009-1012.
10.1002/pbc.22970
PubMed Web of Science® Google Scholar
11Young NS. Current concepts in the pathophysiology and treatment of aplastic anemia. Hematology Am Soc Hematol Educ Program. 2013; 2013: 76-81.
10.1182/asheducation-2013.1.76
PubMed Web of Science® Google Scholar
12Luzzatto L, Risitano AM. Advances in understanding the pathogenesis of acquired aplastic anaemia. Br J Haematol. 2018; 182(6): 758-776.
10.1111/bjh.15443
PubMed Web of Science® Google Scholar
13Ballen KK, Verter F, Kurtzberg J. Umbilical cord blood donation: public or private? Bone Marrow Transplant. 2015; 50(10): 1271-1278.
10.1038/bmt.2015.124
CAS PubMed Web of Science® Google Scholar
14Wall D. Umbilical cord blood: importance of supporting public banks. Am Fam Physician. 2011; 84(6): 638.
PubMed Web of Science® Google Scholar
15Ballen KK, Gluckman E, Broxmeyer HE. Umbilical cord blood transplantation: the first 25 years and beyond. Blood. 2013; 122(4): 491-498.
10.1182/blood-2013-02-453175
CAS PubMed Web of Science® Google Scholar
16Munoz J, Shah N, Rezvani K, et al. Concise review: umbilical cord blood transplantation: past, present, and future. Stem Cells Transl Med. 2014; 3(12): 1435-1443.
10.5966/sctm.2014-0151
CAS PubMed Web of Science® Google Scholar
17Sideri A, Neokleous N, Brunet De La Grange P, et al. An overview of the progress on double umbilical cord blood transplantation. Haematologica. 2011; 96(8): 1213-1220.
10.3324/haematol.2010.038836
PubMed Web of Science® Google Scholar
18Hashem H, Lazarus HM. Double umbilical cord blood transplantation: relevance of persistent mixed-unit chimerism. Biol Blood Marrow Transplant. 2015; 21(4): 612-619.
10.1016/j.bbmt.2014.09.003
PubMed Web of Science® Google Scholar

Citing Literature

Volume23, Issue1

February 2019

e13320

Successful long-term hematological and immunological reconstitution by autologous cord blood transplantation combined with post-transplant immunosuppression in two children with severe aplastic anemia

Correction(s) for this article

Corrigendum

Abstract

REFERENCES

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Successful long-term hematological and immunological reconstitution by autologous cord blood transplantation combined with post-transplant immunosuppression in two children with severe aplastic anemia

Correction(s) for this article

Corrigendum

Abstract

REFERENCES

Citing Literature

References

Related

Information